ArticleCell communication and signaling : CCS2022

DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway.

Xuan Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.